MARA Holdings
MARA
Lennar Corp
LEN
Adobe
ADBE
Apple
AAPL
Vale SA
VALE
US Stock MarketDetailed Quotes
AVXL Anavex Life Sciences
- 7.850
- -0.220-2.73%
Close Feb 27 16:00 ET
- 7.843
- -0.007-0.09%
Post 19:31 ET
667.75MMarket Cap-14.27P/E (TTM)
8.400High7.830Low746.51KVolume8.150Open8.070Pre Close6.02MTurnover0.91%Turnover RatioLossP/E (Static)85.06MShares14.44152wk High6.02P/B647.43MFloat Cap3.25052wk Low--Dividend TTM82.47MShs Float31.500Historical High--Div YieldTTM7.06%Amplitude0.600Historical Low8.068Avg Price1Lot Size
Anavex Life Sciences News
JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15
Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and Applied DNA Sciences (APDN)
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $42
Buy Rating for Anavex Life Sciences Due to Solid Financials and European Market Potential
Anavex Life Sciences Analyst Ratings
Anavex Life Sciences Price Target Maintained With a $46.00/Share by D. Boral Capital
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital
Anavex Life Sciences Analyst Ratings
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $42
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $42
Promising Long-Term Benefits and Market Potential of Blarcamesine in Alzheimer's Treatment Justify Buy Rating for Anavex Life Sciences
Anavex Life Sciences Analyst Ratings
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Raises Target Price to $42
Anavex Life Sciences: Buy Rating Driven by European Approval Prospects and Strong Financial Position
Anavex Life Sciences Analyst Ratings
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital
Anavex Life Sciences Price Target Maintained With a $46.00/Share by D. Boral Capital
H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40
Anavex Life Sciences Analyst Ratings
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.